Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03610165 · ClinicalTrials.gov registry record · NA

Hypotension Prediction Index for Blood Pressure Management

A NA study of Intraoperative Hypotension, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
214
Enrollment target
1
Study location

NCT03610165 is a NA study of Intraoperative Hypotension that has completed, run by The Cleveland Clinic. The registered enrollment target is 214 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03610165, a NA study of Intraoperative Hypotension, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
214 participants
Enrollment target
1
Study location

Study Summary

Design: Single-center randomized comparison of invasive arterial pressure monitoring vs. arterial pressure monitoring combined with Acumen Hypotension Prediction Index (HPI) software guidance on intraoperative hypotension duration and severity. Aim: To determine whether use of Acumen HPI software guidance to guide intraoperative hemodynamic management in the non-cardiac surgery reduces the duration and severity of hypotension. Primary hypothesis: Our primary hypothesis is that adding Acumen HPI software guidance to the information provided by the invasive arterial pressure monitoring during moderate- to high-risk noncardiac surgery reduces time-weighted average (TWA) intraoperative hypotension below a threshold of 65 mmHg.

Conditions Studied

Interventions

  • DEVICE Control
  • DEVICE Acumen HPI-enabled EV1000 screen

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 214 participants
Start Date 2018-07-12
Est. Completion 2021-03-31
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT03610165

The ClinicalTrials.gov registry entry for NCT03610165 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intraoperative Hypotension appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT03610165 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03610165 about?

NCT03610165 is a clinical study titled "Hypotension Prediction Index for Blood Pressure Management". Design: Single-center randomized comparison of invasive arterial pressure monitoring vs. arterial pressure monitoring combined with Acumen Hypotension Prediction Index (HPI) software guidance on intraoperative hypotension duration and severity. Aim: To determine whether use of Acumen HPI software g...

What is the current status of trial NCT03610165?

This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2018-07-12. Estimated completion is 2021-03-31.

What conditions does trial NCT03610165 study?

This clinical trial studies the following conditions: Intraoperative Hypotension.

What interventions are being tested in trial NCT03610165?

The interventions under investigation include: Control (DEVICE), Acumen HPI-enabled EV1000 screen (DEVICE).

Who is sponsoring clinical trial NCT03610165?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03610165 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intraoperative Hypotension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.